JNOV, New Trial Denied For GlaxoSmithKline In $3M Paxil Suicide Case

Mealey's (September 20, 2017, 11:17 AM EDT) -- CHICAGO — An Illinois federal judge on Sept. 14 denied judgment as a matter of law or a new trial for GlaxoSmithKline LLC (GSK) in a Paxil suicide case that ended in a $3 million verdict (Wendy B. Dolin, et al. v. GlaxoSmithKline LLC, No. 12-6403, N.D. Ill., Eastern Div., 2017 U.S. Dist. LEXIS 148966)....

Attached Documents

Related Sections